pf-07328948
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 17, 2022 (NCT05654181)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07269301 | Phase 1 | Dec 15, 2025 | Pfizer |
| NCT06991257 | Phase 2 | Jun 19, 2025 | Pfizer |
| NCT05807490 | Phase 1 | Apr 5, 2023 | Pfizer |
| NCT05654181 | Phase 1 | Oct 17, 2022 | Pfizer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 4 | 4 | 2 | 2022 |
1 organizations
Page 1 / 1